IQVIA slides after Q4 results as earnings outlook underwhelms
Source: SeekingAlpha
2026-02-05 10:49:39 ET
More on IQVIA
- IQVIA: Increasingly Indispensable In Drug Development
- IQVIA Holdings Inc. (IQV) Presents at UBS Global Healthcare Conference 2025 Transcript
- IQVIA Q4 2025 Earnings Preview
- CROs fall as FDA head Makary says drug approvals will require fewer trials
- Seeking Alpha’s Quant Rating on IQVIA
Read the full article on Seeking Alpha
For further details see:
IQVIA slides after Q4 results as earnings outlook underwhelms
ICON plc
NASDAQ: ICLR
ICLR Trading
-1.51% G/L:
$100.74 Last:
197,798 Volume:
$102.40 Open:
ICLR Latest News
March 24, 2026 08:00:00 am
ICON and Advarra Introduce New 'Research-Ready,' Connected Site Network Model
ICLR Stock Data
$12,092,532,216
80,264,243
5.3%
228
N/A
Biotechnology & Life Sciences
Healthcare
IE
Dublin 18
